Skip to main content
Caplight Logo









Japan Agency for Medical Research and Development

Japan Agency for Medical Research and Development

Tokyoamed.go.jp

Overview

A Japanese government funding agency established in 2015 to promote integrated medical research and development, from basic research to practical applications. It aims to accelerate the translation of research into healthcare solutions by consolidating R&D budgets from multiple ministries and providing streamlined support for projects in areas like regenerative medicine, rare diseases, infectious diseases, and oncology.

Portfolio Companies

29

Website

amed.go.jp

Investments

Japan Agency for Medical Research and Development investments
CompanyDateStageLead
Celaid TherapeuticsOct 2026Series BCo-investor
Fvital Inc.Jul 2026GrantLead
TAGCyx Biotechnologies Inc.Apr 2026GrantCo-investor
United Immunity, Co., Ltd.Feb 2026GrantCo-investor
EVA Therapeutics, Inc.Jan 2026GrantCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTokyo
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?